Redsense Medical AB (Publ.) Annual Report 2025

Halmstad, Sweden, April 8, 2026 – Redsense Medical AB (publ) (“Redsense'' or “the Company”) announces that the English translation of the Company’s Annual report for 2025 is now available – both attached to this press release as well as on the Company’s website: https://redsensemedical.com/investors-media/financial-reports/

ABOUT REDSENSE MEDICAL

Redsense Medical is a corporate group with operations mainly in Europe and the United States. The company has developed the Redsense System, an innovation used for monitoring and alarm in the case of blood leakage in connection with a hemodialysis treatment. Redsense Medical solves one of the most serious remaining safety problems within hemodialysis – to quickly detect Venous Needle Dislodgement and catheter eakage to minimize blood leakage. The system consists of a patented fiber optic sensor, designed for either venous needle or central venous catheter, which is connected to an alarm unit. From the very start, the development of the company's technology has been based on the demands and safety requirements of healthcare providers in the dialysis sector. The Redsense Medical share is listed on Spotlight Stock Market (REDS)

Contact information

For more information, please contact:
Sebastien Bollue, CEO
Telephone: +46 72-171 1264
E-mail: sebastien.bollue (at) redsensemedical.com

Redsense Medical AB (publ), 556646-4862

Läs mer på Cision